Tau Peptide (306-317) CAS 1003007-59-7

Xa kev nug
Tau Peptide (306-317) CAS 1003007-59-7
Paub meej
CAS Nr .:
Ib ntus:
Peb kuj muab cov lus qhia tshwj xeeb los ntawm crude mus rau 98% purity, thov hu rau peb kom paub meej!

Cov ntaub ntawv ntsig txog
COA/MS/HPLC Report
Peptide Dissolution thiab Cia Phau Ntawv Qhia
Kev faib tawm yam khoom
Tubulin Peptides
Share to
Hauj lwm lawm

Shanghai Sunite Biotechnology Co., Ltd. yog ib qho ntawm cov ua lag luam thiab cov muag khoom ntawm tau peptide (306-317) cas 1003007-59-7 hauv Suav teb, kuj txhawb kev pabcuam kev cai. Txais tos rau cov lag luam wholesale bulk zoo tau peptide (306-317) cas 1003007-59-7 los ntawm peb lub hoobkas. Tiv tauj peb kom paub meej ntxiv.

 

Khoom npe CAS: 1003007-59-7; Tau Peptide (306-317)
Ib ntus  
Peb tsab ntawv ib ntus  
Peptide purity (HPLC, %)  
Cov mis mos molecular  
Molecular Luj (Da)  

 

Product Basic Information Table

 

Khoom Lub Npe Lus Askiv

Product Abbreviation / Alias

Function Tags (comma-sib cais)

Amino Acid Tag Nrho Lub Npe Sequence

Molecular Formula

Qhov hnyav Molecular (Da)

Qhov Nruab Nrab Molecular Luj (Da)

Terminal Hloov kho - N-terminus

Terminal Hloov kho - C-terminus

Qhov ntev (aa)

Tau Peptide (306-317)

#Tau(306-317) #Tau microtubule-binding repeat fragment; #PHF aggregation core peptide; #Tau phosphorylation pathology tshawb fawb

Tau aggregation, paired helical filament (PHF) formation, microtubule assembly, kinase substrate, Alzheimer's disease, neurodegeneration

Serine-Lysine-Valine-Serine-Serine-Proline-Serine-Serine-Serine-Serine-Proline-Serine

C₅₄H₉₀N₂₀O₂₇

1414.635

1415.42

Tsis hloov

Dawb carboxyl pawg

12

 

Physicochemical Solubility & Cia Parameters

 

Khoom Code

Qhov tshwm sim

Pom zoo Dissolution Protocol (los ntawm hnyav)

Solubility Reference

Tsis pom zoo Solvents

Ntev - Lub Sij Hawm Cia Cov Cai

Luv -Lub Sijhawm Cia Cov Cai

Kua Stability

Khoom hmoov ruaj khov

Muaj feem xyuam pH Range

PEB-Tau02

Dawb lyophilized hmoov

Dilute acetic acid, dej ultrapure; Tsawg solubility nyob rau hauv nruab nrab cov dej ntshiab, ntxiv glacial acetic acid los txhim kho solubility

Ntau dua lossis sib npaug li 10mg / mL hauv 0.1% aqueous acetic acid

Tsis muaj dej ntshiab, alkane organic solvents

-20 degree, kaw kom deb ntawm lub teeb, aliquoted, tsis txhob rov khov-thaw

2-8 degree, siv hauv 1 lub hlis; npaj tshiab ua ntej kev sim

Ruaj khov rau 24 teev ntawm 4 degree

3 xyoos ntawm -20 degree, 2 xyoos ntawm 4 degree

3.0-7.0

 

Functional Description

 

Khoom Code

Frontend Short Summary (rau cov npe tshawb nrhiav)

Cov lus piav qhia txog kev ua haujlwm lom neeg lom neeg

Cov cheeb tsam tshawb fawb (comma- cais)

Hom phiaj / Receptor

PEB-Tau02

Tau (306-317) yog cov tub ntxhais PHF6 aggregation fragment ntawm tib neeg Tau protein nrog ntau phosphorylatable serine residues, siv los tsim hauv vitro neurofibrillary tangle qauv

Tau Peptide (306-317) yog PHF6 core sequence nyob rau hauv microtubule-binding domain of Tau protein, thaj tsam tseem ceeb mediating tau oligomerization, paired helical filaments (PHF) thiab neurofibrillary tangle los ua ke. Cov kab ke muaj ntau yam Ser-Pro kinase lees paub motifs, ua haujlwm raws li canonical substrate rau tau-kinases suav nrog GSK-3 thiab CDK5. Nyob rau hauv physiological tej yam kev mob, nws khi thiab stabilizes neuronal microtubules; hyperphosphorylation ua rau dissociation ntawm microtubules thiab spontaneous self-aggregation. Dav siv nyob rau hauv vitro assays rau tau aggregation inhibitor kev tshuaj ntsuam, kinase kev ntsuas ntsuas, pathological mechanism kawm ntawm Alzheimer's kab mob & frontotemporal dementia, neurotoxicity cell qauv, tsim nyog rau neuropathology thiab hloov kho protein ntau kev tshawb fawb pharmacology.

Cov kab mob neurodegenerative, Alzheimer's kab mob, tau protein aggregation, paired helical filaments (PHF), kinase ntsuam xyuas, microtubule dynamics

GSK-3, CDK5, Tubulin, Tau homo-oligomers

 

Cov Ntaub Ntawv Tswj Xyuas Zoo

 

Khoom Code

Purity Detection Method

Molecular Weight Verification Method

Kev Tswj Xyuas Qhov Ntsuas

Impurity Control Standards

PEB-Tau02

Rov qab-theem HPLC

ESI-MS Mass Spectrometry

Purity, dej ntsiab lus, acetate ntsev, hnyav hlau

Ib qho impurity Tsawg dua lossis sib npaug li 2%, tag nrho impurities Tsawg dua lossis sib npaug li 5%

 

SKU Specifications & Inventory Table

 

SKU Unique Code

Yam khoom Code

HPLC Purity

Ntim Specification

Lub Sijhawm Ua Haujlwm Ntau Lawm

Customizable

Optional Custom Modifications

Cov ntaub ntawv suav nrog

PEP-Tau02-98-1

PEB-Tau02

Ntau dua lossis sib npaug li 98%

1mg ib

3-7 hnub ua haujlwm

Yog lawm

Acetylation, amidation, fluorescent labeling, biotin labeling

CoA, HPLC chromatogram, MS mass spectrum

PEP-Tau02-98-5

PEB-Tau02

Ntau dua lossis sib npaug li 98%

5mg ib

3-7 hnub ua haujlwm

Yog lawm

Acetylation, amidation, fluorescent labeling, biotin labeling

CoA, HPLC chromatogram, MS mass spectrum

PEP-Tau02-95-1

PEB-Tau02

Ntau dua lossis sib npaug li 95%

1mg ib

3-7 hnub ua haujlwm

Yog lawm

Acetylation, amidation, fluorescent labeling, biotin labeling

CoA, HPLC chromatogram, MS mass spectrum

Cim npe nrov: Tau peptide (306-317) cas 1003007-59-7, Tuam Tshoj tau peptide (306-317) cas 1003007-59-7 manufacturers, lwm tus, Hoobkas

Xa kev nug